Screening Study of the Anxiolytic Activity of New Triazole Compounds
DOI:
https://doi.org/10.62480/tjms.2022.vol13.pp43-46Keywords:
triazole compounds, seduxene, anxiolytic, raised cruciform labyrinthAbstract
The article presents data on the study of the anxiolytic activity of compounds representing new triazole derivatives – combinations of two privileged structures. At the "Raised Cruciform labyrinth" installation, such indicators of the studied compounds, the time of exit into the open sleeve, the number of exits and the total time spent in it were studied that the D-389 compounds are not inferior to the comparison drug, which indicates the presence of high anxiolytic activity.
References
Гурович И. Я., Шмуклер А. Б. // Социальная и клиническая психиатрия. – 2011. – Т. 21, № 4. – С. 51–57.
Воронина Т. А. // Руководство по проведению доклинических исследований лекарственных средств: под ред. А. Н. Миронова. – 2012. – Ч. 1. – С. 264–275.
Морковник А. С., Спасов А. А., Кузьменко Т. А., с соавт. // Известия Академии наук. Серия химическая. – 2015. – № 11. – С. 2622.
Чепляева Н. И., Кузнецова В. А., Спасов А. А., с соавт. // Волгоградский научно-медицинский журнал. – 2014. – № 3 (43). – С. 21–24.
Хабриев Р.У. // Руководство по экспериментальному изучению новых фармакологических веществ. – 2005. – С. 78-80.
X.Q. Deng, L.N. Quan, M.X. Song, C.X. Wei, Z.S. Quan, Zhe-Shan Quan, Synthesis and anticonvulsant activity of 7-phenyl-6,7-dihydro-[1,2,4] triazolo [1,5-a] pyrimidin-5(4H)-ones and their derivatives, Eur. J. Med. Chem. 46 (2011) 2955-2963.
M. Faizi, S. Dabirian, H. Tajali, F. Ahmadi, E.R. Zavareh, S. Shahhosseini, S.A. Tabatabai, Novel agonists of benzodiazepine receptors: design, synthesis, binding assay and pharmacological evaluation of 1,2,4-triazolo[1,5-a]pyrimidinone and 3-amino-1,2,4-triazole derivatives, Bioorg. Med. Chem. 23 (2015) 480-487.
Rashidov S.Z., Rakhimboev S.D., Sanoev Z.I., Abdinazarov I.T., Khamroev T.T., Ismailova D.S., & Elmuradov B.J. (2022). Study of psychoactive activity potassium salt 5-(o-aminophenyl)-1,3,4- oxadiazole-2-thion (D-361). International Journal of Medical Sciences And Clinical Research, 2(09), 1–5. https://doi.org/10.37547/ijmscr/Volume02Issue09-01
Sanoev Z.I., Mirzaev Yu.R. Pharmacological Activity Of The Possessing New Atypical Neuroleptics 1-Phenyltetrahydroisoquinoline Structure. The American Journal of Medical Sciences and Pharmaceutical Research Published: 2020|Pages:18-26 https://doi.org/10.37547/TAJMSPR/Volume02Issue08-03
Sanoev, Z.I., Mirzaev, Y.R. Research of a new atypical neuroleptic 1-(3,4,-methylenedioxyphenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline on the central nervous system. Annals of the Romanian Society for Cell Biology, 2021,25(2), 2363–2369
Саноев З.И., Мирзаев Ю.Р., Якубова Л.К. Сравнительного фармакологического свойства производного тетрагидроизохинолина и седуксена. Новый день в медицине. Научно – реферативный, духовно-просветительский журнал. 2 (30/2) 2020, с. 365-368
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
